Infectious Disease Diagnostics Market, By Technique (ELISA, Polymerase Chain Reaction, Immunoassays, Cell Cultures, Others), By Disease Indication (CNS Infection (Meningitis, Brain Abscess), Diarrheal Disease (Shigellosis, Cholera, Enteric/Typhoid Fever),

Infectious Disease Diagnostics Market, By Technique (ELISA, Polymerase Chain Reaction, Immunoassays, Cell Cultures, Others), By Disease Indication (CNS Infection (Meningitis, Brain Abscess), Diarrheal Disease (Shigellosis, Cholera, Enteric/Typhoid Fever), Respiratory Infections (Tuberculosis, Influenza, Bronchitis), Blood Infections (Malaria, Dengue, Infectious Mononucleosis, Others), STDs (Chlamydia, AIDS, Syphilis, Others)), By End User (Hospitals, Diagnostic Centers, Clinics, Government Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Infectious diseases are caused by organisms such as bacteria, viruses, fungi, and parasites and are capable of transmission from one species to another species. Diagnosis of these diseases involves identifying the pathogen and its type and the degree up to which the infection has spread. Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases. Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, and conventional culturing, and staining techniques. Biochemical techniques include ELISA, agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.
Restraints of the Global Infectious Disease Diagnostics Market
Factors such as high costs of molecular diagnostic tests, and lack of reimbursement is expected to restrain growth of the market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the global infectious disease diagnostics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global infectious disease diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, BioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, Alera Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Infectious Disease Diagnostics Market, By Technique:
ELISA
Polymerase Chain Reaction
Immunoassays
Cell Cultures
Others
Global Infectious Disease Diagnostics Market, By Disease Indication:
CNS Infection
Meningitis
Brain Abscess
Diarrheal Disease
Shigellosis
Cholera
Enteric/Typhoid Fever
Respiratory Infections
Tuberculosis
Influenza
Bronchitis
Blood Infections
Malaria
Dengue
Infectious Mononucleosis
Others
STDs
Chlamydia
AIDS
Syphilis
Others
Global Infectious Disease Diagnostics Market, By End User:
Hospitals
Diagnostic Centers
Clinics
Government Organizations
Global Infectious Disease Diagnostics Market, By Geography:
North America
By Technique
ELISA
Polymerase Chain Reaction
Immunoassays
Cell Cultures
Others
By Disease Indication
CNS Infection
Meningitis
Brain Abscess
Diarrheal Disease
Shigellosis
Cholera
Enteric/Typhoid Fever
Respiratory Infections
Tuberculosis
Influenza
Bronchitis
Blood Infections
Malaria
Dengue
Infectious Mononucleosis
Others
STDs
Chlamydia
AIDS
Syphilis
Others
By End User
Hospitals
Diagnostic Centers
Clinics
Government Organizations
By Country:
U.S.
Canada
Europe
By Technique
ELISA
Polymerase Chain Reaction
Immunoassays
Cell Cultures
Others
By Disease Indication
CNS Infection
Meningitis
Brain Abscess
Diarrheal Disease
Shigellosis
Cholera
Enteric/Typhoid Fever
Respiratory Infections
Tuberculosis
Influenza
Bronchitis
Blood Infections
Malaria
Dengue
Infectious Mononucleosis
Others
STDs
Chlamydia
AIDS
Syphilis
Others
By End User
Hospitals
Diagnostic Centers
Clinics
Government Organizations
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Technique
ELISA
Polymerase Chain Reaction
Immunoassays
Cell Cultures
Others
By Disease Indication
CNS Infection
Meningitis
Brain Abscess
Diarrheal Disease
Shigellosis
Cholera
Enteric/Typhoid Fever
Respiratory Infections
Tuberculosis
Influenza
Bronchitis
Blood Infections
Malaria
Dengue
Infectious Mononucleosis
Others
STDs
Chlamydia
AIDS
Syphilis
Others
By End User
Hospitals
Diagnostic Centers
Clinics
Government Organizations
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Technique
ELISA
Polymerase Chain Reaction
Immunoassays
Cell Cultures
Others
By Disease Indication
CNS Infection
Meningitis
Brain Abscess
Diarrheal Disease
Shigellosis
Cholera
Enteric/Typhoid Fever
Respiratory Infections
Tuberculosis
Influenza
Bronchitis
Blood Infections
Malaria
Dengue
Infectious Mononucleosis
Others
STDs
Chlamydia
AIDS
Syphilis
Others
By End User
Hospitals
Diagnostic Centers
Clinics
Government Organizations
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Technique
ELISA
Polymerase Chain Reaction
Immunoassays
Cell Cultures
Others
By Disease Indication
CNS Infection
Meningitis
Brain Abscess
Diarrheal Disease
Shigellosis
Cholera
Enteric/Typhoid Fever
Respiratory Infections
Tuberculosis
Influenza
Bronchitis
Blood Infections
Malaria
Dengue
Infectious Mononucleosis
Others
STDs
Chlamydia
AIDS
Syphilis
Others
By End User
Hospitals
Diagnostic Centers
Clinics
Government Organizations
By Country:
GCC
Israel
Rest of Middle East
Africa
By Technique
ELISA
Polymerase Chain Reaction
Immunoassays
Cell Cultures
Others
By Disease Indication
CNS Infection
Meningitis
Brain Abscess
Diarrheal Disease
Shigellosis
Cholera
Enteric/Typhoid Fever
Respiratory Infections
Tuberculosis
Influenza
Bronchitis
Blood Infections
Malaria
Dengue
Infectious Mononucleosis
Others
STDs
Chlamydia
AIDS
Syphilis
Others
By End User
Hospitals
Diagnostic Centers
Clinics
Government Organizations
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Becton Dickinson & Company *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Cepheid, Inc.
Abbott Laboratories
BioMerieux SA
Hologic, Inc.
Danaher Corporation
Thermo Fisher Scientific, Inc.
Roche Diagnostics
DiaSorin S.p.A.
Quidel Corporation
Bio-Rad Laboratories, Inc.
“*” marked represents similar segmentation in other categories in the respective section.